Journal of Hypertension

Papers
(The H4-Index of Journal of Hypertension is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
In remembrance: the life and legacy of George L. Bakris (1952–2024)1081
Cardiovascular responses to experimental weight gain in humans: a feasibility study444
Association of longitudinal changes in 24-h blood pressure level and variability with cognitive decline99
Association between lung function and hypertension and home hypertension in a Japanese population: the Tohoku Medical Megabank Community-Based Cohort Study92
Activation of the intestinal tissue renin-angiotensin system by transient sodium loading in salt-sensitive rats91
Sympathetic activation by obstructive sleep apnea: a challenging ‘off-label’ meta-analysis66
Effect of parental arterial stiffness in offspring: the Kailuan study62
Arterial stiffness precedes hypertension and metabolic risks in youth: a review54
10. The Association of Intravenous Nitrates Dosing Regimens on Blood Pressure Reduction and ICU Admission Rates among Acute Hypertensive Heart Failure Patients in Emergency Settings: A Systematic Revi48
17. The Effects of Nighttime vs. Morning Dosing of Antihypertensive Medications on Blood Pressure Reduction: A Systematic Review and Meta-Analysis44
55. Incidence and Sex-Specific Predictors of Progression from Prehypertension to Hypertension in Asian Population: A Systematic Review of Cohort Study43
54. The Association Between Preeclampsia and Chronic Kidney Disease: A Systematic Review41
4. Assessment and Validation of Electrocardiographic Diastolic Index for Diagnosing Left Ventricular Diastolic Dysfunction in Patients with Hypertension37
30. Navigating Hypertensive Emergencies: Understanding the Choices Between Nicardipine and Nitroprusside from a Rigorous Systematic Review and Meta-Analysis37
ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE POLYMORPHISM (894G>T, 786T>C) CONTRIBUTE TO HYPERTENSION RISK AND LIPIDS PROFILE DISORDERS36
ESTIMATES OF CARDIOVASCULAR DISEASES BURDEN ATTRIBUTABLE TO HIGH SODIUM INTAKE FROM 1990 TO 2019: A SYSTEMATIC ANALYSIS OF DATA FROM THE GLOBAL BURDEN OF DISEASE STUDY35
EFFECT OF CALCIUM CHANNEL BLOCKERS ON HEART FAILURE: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS33
25(OH)D AS A RISK FACTOR OF ESSENTIAL ARTERIAL HYPERTENSION CONSIDERING THE GENES POLYMORPHISM AGTR1 (RS5186) AND VDR (RS2228570)32
Optimal office blood pressure levels in younger (<50 years old) Korean hypertensive patients: a nationwide cohort study in South Korea31
THE PHARMACOKINETIC PARAMETERS DATA OF THE 20 MOST COMMONLY PRESCRIBED ANTIHYPERTENSIVE MEDICATIONS30
Time-averaged cumulative blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: analysis from the Treatment of Preserved Cardiac Function Heart Failure with an A29
ISCHEMIC REPERFUSION INJURY IN HYPERTENSIVE RAT HEART29
Association of depressive symptoms and hypertension prevalence, awareness, treatment and control among USA adults26
Silent brain infarcts, peripheral vascular disease and the risk of cardiovascular events in patients with hypertension26
Angiotensin II prompts heart cell apoptosis via AT1 receptor-augmented phosphatase and tensin homolog and miR-320-3p functions to enhance suppression of the IGF1R-PI3K-AKT survival pathway25
0.12587308883667